FDA Approves Treatment for Moderate-to-Severe Chronic Hand Eczema
Regulatory approval is based on clinical trials showing improvements in symptom severity and treatment success at 16 weeks.
Regulatory approval is based on clinical trials showing improvements in symptom severity and treatment success at 16 weeks.
Findings suggest that tools designed to elicit patient values can improve communication and support African American women in choosing between implant-based and autologous reconstruction after mastectomy.